Doctors facing grim choice over ventilators told to put patients with disabilities at the back of the line
By Deborah Hellman,
The Conversation
| 04. 20. 2020
In several states, existing policies that were developed in anticipation of an emergency – including pandemics – recommend rationing that prioritizes giving ventilators to otherwise healthy people who are most likely to benefit.
As cases related to the novel coronavirus continue to strain hospitals, doctors face difficult choices about rationing scarce medical resources like ventilators – choices that will likely determine who lives and who dies.
Several states’ policies tell providers to allocate scarce resources to those most likely to benefit. For example, Washington state recently adopted a policy that favors “the survival of young otherwise healthy patients more heavily than that of older, chronically debilitated patients.” Similar new guidelines have been issued in Massachusetts as well.
In several other states, existing policies that were developed in anticipation of an emergency – including pandemics – recommend rationing that prioritizes giving ventilators to otherwise healthy people who are most likely to benefit. The policies may be mandatory in some contexts, depending on state law, but are likely to be influential even when not required.
While seemingly sensible, policies that focus exclusively on saving as many lives as possible may miss something just as important about whose life is spared and whose is not.
As a scholar who studies the law and ethics of discrimination...
Related Articles
By Dan Barry and Sonia A. Rao, The New York Times | 01.26.2026
Photo by Gage Skidmore from Peoria, AZ, United States
of America, CC BY-SA 2.0, via Wikimedia Commons
Late last month, a woman posted a photograph on social media of a purple hat she had knitted, while a black-and-white dog...
By Shobita Parthasarathya, Science | 01.22.2026
These are extraordinarily challenging times for university researchers across the United States. After decades of government largess based on the idea that a large and well-financed research ecosystem will produce social and economic progress, there have been huge cuts in...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...